Pharmacological Management of Sexual Dysfunction in Females

Abstract

Human sexuality has multiple facets and dimensions. Treatment of sexual dysfunctions and been
attempted since ages. However, there has been limited progress in management of sexual dysfunctions
in females. Flibanserin is a recently approved molecule for treatment of hypoactive sexual desire
disorder (HSDD) in females. It is a 5-HT receptor agonist and 5-HT receptor antagonist. Other
treatment modalities include local and systemic hormonal agents including estrogen, progesterone,
testosterone, ospemifene and tibolone. Combination treatments are also being investigated. To provide
holistic care to the patient, one must always include psychological treatments in the management plan
of the patient.